Predictably, the drug combinations cooperatively blocked constitutive and Wnt3a-induced SOX4 expressions in cancer cell lines (Fig. 5b-c, and Supplementary Fig. S9b-c), and this effect was rescued in DDIT3−/− cells (Fig. 5d). Here, WNT3A is linked to cancer.